Provotorov V M, Kazabtsov A Iu
Ter Arkh. 1997;69(3):19-23.
The authors studied expectoration, cough clearance and immunity in 48 patients with exacerbation of chronic obstructive pulmonary affections (COPA) associated with lymphoproliferative diseases (chronic lymphoid leukemia, lymphocytic lymphoma, myeloma) versus 16 control patients suffering from COPA alone. patients of the test group received cytostatics and steroids according to standard schemes. They are shown to develop aggravation of immune defects with emergence of persistent secondary immunodeficiency, more marked disturbance of tracheobronchial clearance with more frequent occurrence of persistent ciliary dyskinesia. This resulted in slower relief of clinical symptoms, more severe course dictating the necessity of longer treatment, the addition of immunocorrectors, antibacterial drugs without immunosuppressive action.
作者对48例合并淋巴增殖性疾病(慢性淋巴细胞白血病、淋巴细胞淋巴瘤、骨髓瘤)的慢性阻塞性肺疾病加重期(COPA)患者与16例单纯患有COPA的对照患者的咳痰、咳嗽清除功能及免疫力进行了研究。试验组患者按照标准方案接受了细胞抑制剂和类固醇治疗。结果显示,他们出现了免疫缺陷加重,伴有持续性继发性免疫缺陷的出现,气管支气管清除功能受到更明显的干扰,持续性睫状运动障碍的发生率更高。这导致临床症状缓解较慢,病程更严重,需要更长时间的治疗,加用免疫调节剂、无免疫抑制作用的抗菌药物。